Generali has some scope to think bigger on M&A
The author is a Reuters Breakingviews columnist. The opinions expressed are her own.
By Lisa Jucca
MILAN, March 12 (Reuters Breakingviews) -Philippe Donnet’s next M&A step could define his legacy. Under the Assicurazioni Generali GASI.MI CEO’s eight-year watch, Italy’s top insurer clinched 10 billion euros’ worth of deals. Even so, a group of large investors who unsuccessfully tried to unseat him in 2022 has argued that the 35 billion euro ($38 billion) group needs to be more aggressive. Daring to target larger players like $16 billion Aviva AV.L, as suggested in a Bloomberg report last week, may be easier than it looks.
Donnet’s no-nonsense approach in running Generali has borne fruit: since taking the helm in 2016, shareholder returns including dividends have approached 160%, roughly in line with German rival Allianz ALVG.DE but better than France’s AXA’s AXAF.PA 137% over the same period. Yet Generali’s market capitalisation is half that of Axa and a third that of Allianz, and it has fewer customers.
To bulk up, Donnet could consider bigger acquisitions. Two issues complicate that goal, though. One is that most potential targets for Generali, which trades on 9 times expected 2024 earnings on LSEG estimates, look tricky. Smaller fry like Austria’s 4 billion euro Vienna Insurance Group VIGR.VI, the Netherlands’ 10 billion euro Aegon AEGN.AS and Belgium’s 7 billion euro Ageas AGES.BR trade on lower multiples, but all have potentially meddlesome shareholders. The 12 billion euro NN Group NN.AS looks excessively focused on its home market. Britain’s Aviva, meanwhile, trades on 11 times 2024 earnings and would thus dilute existing Generali investors’ earnings per share, particularly as Donnet would probably need to pay a tangible premium.
That leads to the other issue. Going large on M&A probably means an equity hike, as higher rates make debt expensive. That’s tricky, given Generali’s key investors tend not to see eye to eye. Investment bank Mediobanca, the top shareholder with a 13% stake, has backed Donnet before. Yet Italian entrepreneur Francesco Gaetano Caltagirone and the Del Vecchio and Benetton clans, whose separate holdings make up 21% of Generali, have criticised Donnet in the past. These players may also soon get a bigger say in board appointments thanks to a new Italian capital markets law.
Yet Donnet has some positives. He may have opponents on the shareholder register, but more adventurous M&A is what Caltagirone and his backers have been pushing him to do. Moreover, two factors could help a Generali M&A splurge.
One is its solvency position. The Italian insurer, which announced record annual earnings on Tuesday, has set the lower end of the capital it would be comfortable operating with at 180% of requirements, which as of end-December were 22 billion euros. That implies 40 billion euros of capital, against 47 billion euros now – implying 7 billion euros of cash to spend on deals, according to Breakingviews calculations.
Another potential help is 4 billion euro asset manager Banca Generali, which Generali part-owns and which Mediobanca CEO Alberto Nagel has long coveted. If Donnet offered that, Nagel might be tempted to sell his own 5 billion euro stake in Generali to finance his deal. Cutting the long-standing umbilical cord between Mediobanca and Italy’s biggest insurer might in turn placate Generali’s other big investors sufficiently to make them back a move for the likes of Aviva.
That would still leave some challenges, like the difficulty of selling Mediobanca’s stake quickly onto the market. Even so, Donnet looks to have room for a share-based swoop on a sizable rival, with a chunky cash component. There’s some scope for a tenure-defining big deal, a simplified Generali shareholder register, and possibly even both.
Follow @LJucca on X
CONTEXT NEWS
Assicurazioni Generali said on March 12 that its 2023 operating profit had risen by 7.9% to a record high of 6.9 billion euros, in line with a consensus of analysts’ estimates provided by the company. Adjusted net profit rose 14.1% to 3.6 billion euros, also a record high.
Italy’s top insurer Generali, worth 35 billion euros ($38 billion), is analysing a range of potential takeover candidates, some of which are worth more than 10 billion euros, Bloomberg reported on March 6 citing people familiar with the matter.
Aviva CEO Amanda Blanc describes the takeover speculation as “largely market chatter”, according to an article by the Telegraph published on March 7. Generali CEO Philippe Donnet said on March 12 that the insurer would consider M&A deals if they create value for all stakeholders in a disciplined way.
The list of possible targets includes 13 billion pound ($16 billion) British insurer Aviva and 12 billion euro NN Group, as well as smaller insurance operators.
Investment bank Mediobanca, which is Generali’s top shareholder with a 13% stake, has backed CEO Donnet, at the helm since 2016. The Del Vecchio family, which owns 10% of Generali, and the Caltagirone Group, which owns 6%, have however been critical of Donnet and backed an alternative board slate during a 2022 proxy fight.
A recently approved Italian bill is set to give minority shareholders a bigger say when appointing board directors.
Shares in Generali were up 0.6% at 22.43 euros as of 0850 GMT on March 12.
Graphic: Generali’s performance under CEO Philippe Donnet https://reut.rs/48PYPcX
Editing by George Hay and Oliver Taslic
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
